Physician

Michael James Drass, MD

According to 2025 Medicare claims, Michael Drass, MD (NPI: 1225144520) practices anesthesiology in the Altoona, PA market, with the plurality of this provider's patient population coming from Blair, PA. This provider's primary affiliated billing organization is ALLEGHENY PAIN MANAGEMENT PC (NPI: 1619986528; TIN: 251898277) and primary practice location at 16602-2415.

Drass' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 467 traditional Medicare patients, billed 4,760 HCPCS/CPT codes, and received $199,649 in Medicare payments. The top billing code was 64635 (Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint). Part D data shows 4,063 prescription claims across 539 beneficiaries totaling $502,696 in drug costs, led by Xtampza Er (Oxycodone Myristate). DME data shows 21 claims. Open Payments data shows 66 records totaling $2,312. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $197,534 and ending at $199,649. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $207,819 to $502,696. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	514	4,690	$197,534
2016	542	6,216	$208,325
2017	486	5,067	$211,471
2018	534	5,270	$217,362
2019	522	4,804	$241,868
2020	390	1,921	$133,158
2021	388	4,695	$196,756
2022	356	3,959	$154,633
2023	408	3,814	$128,477
2024	467	4,760	$199,649

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	311	1,408	$207,819
2016	310	1,540	$225,216
2017	289	1,905	$276,874
2018	295	3,481	$537,566
2019	269	3,013	$457,054
2020	274	3,024	$441,022
2021	294	3,333	$464,347
2022	327	3,626	$517,954
2023	348	3,464	$505,244
2024	539	4,063	$502,696

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	42	$1,716
2016	N/R	37	$1,346
2017	N/R	N/R	N/R
2018	N/R	45	$2,967
2019	N/R	39	$2,343
2020	N/R	31	$1,916
2021	N/R	12	$724
2022	N/R	31	$1,596
2023	N/R	N/R	N/R
2024	N/R	21	$1,776

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64635	Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint	71	79	$227
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	70	87	$94
27096	Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance	98	168	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	367	880	$70
64636	Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint	71	80	$68

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtampza Er	Oxycodone Myristate	103	3,060	$145,139
Oxycontin	Oxycodone Hcl	115	3,400	$138,851
Relistor	Methylnaltrexone Bromide	13	390	$30,454
Nucynta	Tapentadol Hcl	22	660	$23,213
Fentanyl	Fentanyl	100	2,965	$19,286

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0745	Neuromuscular stimulator, electronic shock unit	Y	N/R	21	$1,776

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	66	$2,312	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael James Drass, MD?

Tedicare shows public-source Medicare data for Michael James Drass, MD (NPI 1225144520), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael James Drass, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael James Drass, MD?

Michael James Drass, MD is linked to ALLEGHENY PAIN MANAGEMENT PC (billing NPI 1619986528) in the available physician profile data.

Does Michael James Drass, MD have Open Payments data?

Michael James Drass, MD has 66 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.